Comparison of hemodynamic data between current commercially available... | Download Table
Xeltis - Home | Facebook
Xeltis (@Xeltis) / Twitter
Swiss medtech startup Xeltis raises €10.5 million to develop its novel tissue regeneration treatment for heart disease | EU-Startups
News - Xeltis
Xeltis initiates European first-in-human trial of restorative haemodialysis access graft - Renal Interventions
News - Xeltis
Xeltis initiates the first-ever pivotal trial of a synthetic restorative pulmonary heart valve - Innovation Origins
Xeltis accelerating clinical trial program - Xeltis
Interview – Xeltis brings bioabsorbable tech to heart valves
Restorative pulmonary heart valve clinical trial; information for medical professionals
Xeltis initiates first-ever pivotal trial of a synthetic restorative pulmonary heart valve - Xeltis
News - Xeltis
Xeltis Begins Pivotal Trial for Pulmonary Valve That Grows With the Patient | DAIC
Device and Clinical Trial Update: OneShot (Covidien) | tctmd.com
Xeltis BV | BioWorld
Xplore2 Trial Holding - Xplore 2 Trial
Frontiers | A Novel Restorative Pulmonary Valve Conduit: Early Outcomes of Two Clinical Trials | Cardiovascular Medicine
Clinical Design of ASAP-2 | tctmd.com
Frontiers | A Novel Restorative Pulmonary Valve Conduit: Early Outcomes of Two Clinical Trials | Cardiovascular Medicine
Xeltis lands $52M for restorative heart valve technology | Fierce Biotech
Initial Clinical Trial of a Novel Pulmonary Valved Conduit - ScienceDirect
171114 XeltisSeries Release FINAL
Xeltis - Home | Facebook
